| 溶解性 | DMSO |
| 存贮条件 | 储存温度-20°C |
| 生化机理 | LUF6000 is an allosteric modulator of the human A3 adenosine receptor (AR). LUF6000 was found to be an allosteric enhancer of Emax of structurally diverse agonists at the A3 AR, being more effective for low-Emax agonists than for high-Emax agonists. LUF6000 exerted an Emax-enhancing effect at a concentration of 0.1 microM or higher, and was shown to increase the Emax of Cl-IB-MECA and other low-efficacy agonists to a larger extent than that of the high-efficacy agonist NECA. Interestingly, LUF6000 converted a nucleoside A3 AR antagonist MRS542, but not a non-nucleoside antagonist MRS1220, into an agonist. |
| 别名 | ; |
LUF6000,A3腺苷受体的变构调节剂
LUF6000 （订货以英文为准）
编号：L127479
CAS号：890087-21-5
分子式：C22H20CL2N4
分子量：411.33
| 产品名称 | LUF6000 |
| 中文名称 | LUF6000,A3腺苷受体的变构调节剂 |
| CAS号 | 890087-21-5 |
| 分子式（M.F.） | C22H20CL2N4 |
| 分子量（M.W.） | 411.33 |
| 储存条件 | -20°C储存 |
搜索质检报告(COA)
搜索MSDS
相关产品
党沛 
